Document is current
Any future updates will be listed below
-
Authors
Cahuzac, Maxime https://orcid.org/0000-0002-5395-8090
Langlois, Patricia https://orcid.org/0000-0003-0255-9708
Péant, Benjamin
Fleury, Hubert
Mes-Masson, Anne-Marie https://orcid.org/0000-0002-6498-266X
Saad, Fred https://orcid.org/0000-0003-2986-5617
-
Funding
Funding for this research was provided by:
Canadian Urological Oncology Group
- License Information
-
More Information
Article History
Received: 13 July 2021
Accepted: 1 March 2022
First Online: 22 March 2022
Competing interests
: F.S. is an advisory board member (personal) and has received research funding (institutional) from AstraZeneca, Pfizer, Astellas, Bayer and Janssen.
